R&D
Typewriter Raises $56M to Ditch Viruses From Gene Therapy
Emerging from stealth, the startup uses a “jumping gene” and lipid nanoparticles to insert therapeutic genes inside the body — a non-viral bet amid mounting safety worries about viral vectors.